Keeping you up to date on recent developments in orthopedics, including: Implant choice more important than surgeon skill for hip replacement success; Vertebral body tethering shows clinical success as treatment for scoliosis; Hip fracture risk linked to nanoscale bone inflexibility; Bioventus reports first use of its Signfuse bioactive bone graft in strip format.
Keeping you up to date on recent developments in orthopedics, including: Hip fracture risk linked to nanoscale bone inflexibility; High intensity physical activity in early life could lead to stronger bones in adulthood; Xtant Medical reports U.S. launch of the Matriform Si; Opioid prescription rates for knee surgery vary, but higher strength dosage common.
Medtronic plc reported first-quarter worldwide revenue of just over $6.5 billion, a decrease of 13% as reported. As Cowen’s Josh Jennings wrote, the company’s results were better than expected, with an organic revenue growth decline of 17% vs. the Street’s prediction of a 25% decrease.
Keeping you up to date on recent developments in orthopedics, including: Simultaneous stimulation helped a spinal cord injury patient regain the ability to walk; Researchers identify better classification system for adult idiopathic scoliosis; Mixing silk with polymers could lead to better biomedical implants.
Keeping you up to date on recent developments in orthopedics, including: Long-term risks of joint implants; New approach to treating osteoarthritis advances; Osmotic therapy device reduces swelling to prevent secondary injuries in rats.
Keeping you up to date on recent developments in orthopedics, including: Implanted neural stem cell grafts show functionality in spinal cord injuries; Silk scaffolds and magnetism to generate bone tissue and be able to use it in implants; Hydrogel paves way for biomedical breakthrough; New strategy against osteoporosis.
Orthopedic companies felt pressure from COVID-19 in their most recent quarters. For example, Zimmer Biomet Holdings Inc. reported second-quarter net sales of $1.226 billion, a decrease of 38.3% from the prior-year period. Still, those revenues did come ahead of expectations, as Wells Fargo analyst Larry Biegelsen noted – $432 million ahead of his group's estimate and $305 million ahead of consensus.
A bioelectronic platform that stimulates the vagus nerve to reduce inflammatory activity and restore balance in the immune system is the ultimate aim of Setpoint Medical Inc. The Valencia, Calif.-based startup is preparing to start a U.S. pivotal trial for its most advanced program in rheumatoid arthritis (RA) later this year or early next.
Keeping you up to date on recent developments in orthopedics, including: Lego-inspired bone and soft tissue repair with tiny, 3D-printed bricks; Mutant zebrafish reveals a turning point in spine's evolution; Newly discovered cells act as a warning signal for rheumatoid arthritis flares.
Keeping you up to date on recent developments in orthopedics, including: Spinal stimulators repurposed to restore touch in lost limb; Genetic testing could improve screening for osteoporosis; Study shows genetic markers are useful in predicting osteoporotic fracture risk.
RSS
